Westchester Capital Management (New York)’s Zimmer Biomet ZBH Stock Holding History

Westchester Capital Management (New York)’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-97,700	Closed	-$12.5M	–	444
2022 Q1	$12.5M	Sell	97,700 -2,931	-3%	-$353K	0.34%	54
2021 Q4	$12.4M	Buy	100,631 +33,578	+50%	+$4.39M	0.35%	39
2021 Q3	$9.53M	Buy	+67,053	New	+$9.86M	0.27%	50

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Westchester Capital Management (New York)'s ZBH Position: Q2 2022 in Review

Westchester Capital Management (New York) sold out of Zimmer Biomet (ZBH) in Q2 2022, closing a stake of 97,700 shares — an estimated $12.5M sold.

Westchester Capital Management (New York) first reported a position in ZBH in Q3 2021 and held it in 3 quarters. The position peaked at $12.5M in Q1 2022. 957 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.

Westchester Capital Management (New York) reported no remaining Zimmer Biomet position as of Q2 2022 after selling out during the quarter.
Westchester Capital Management (New York) sold 97,700 Zimmer Biomet shares in Q2 2022, an estimated $12.5M.
Westchester Capital Management (New York) first reported a position in Zimmer Biomet in Q3 2021 and held it in 3 quarters.
Westchester Capital Management (New York)'s Zimmer Biomet position peaked at $12.5M in Q1 2022.
957 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.

Based on Westchester Capital Management (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.